Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:BPOP
NasdaqGS:BPOPBanks

Is It Too Late To Consider Popular (BPOP) After Strong Multi Year Share Price Gains

If you are wondering whether Popular's share price still reflects good value or if most of the opportunity is already priced in, this article walks through the key signals you can use to form your own view. Popular's shares last closed at US$133.53, with returns of 9.5% over the past 7 days, 7.2% over 30 days, 6.0% year to date, 33.3% over 1 year, 106.6% over 3 years, and 149.1% over 5 years. These figures raise fair questions about what is now built into expectations and perceived...
NasdaqCM:GRRR
NasdaqCM:GRRRSoftware

A Look At Gorilla Technology Group (GRRR) Valuation As AI Trading Models Highlight Positive Near Term Outlook

AI-driven trading interest puts Gorilla Technology Group (GRRR) in focus Recent AI model outputs flagging positive near and mid-term sentiment for Gorilla Technology Group (GRRR) have pulled the stock into the spotlight, as institutional-style trading frameworks emphasize risk-reward trade setups instead of new fundamental catalysts. See our latest analysis for Gorilla Technology Group. Gorilla Technology Group’s share price has been volatile, with a 29.30% 1 month share price return and a...
SWX:AMRZ
SWX:AMRZBasic Materials

Is Amrize’s (SWX:AMRZ) Q4 Earnings Call Set To Reframe Its Long-Term Growth Narrative?

Amrize has announced it will release its fourth-quarter 2025 results after the U.S. market closes on February 17, 2026, followed by a webcast the next morning to discuss the numbers with investors. Fresh analyst coverage, including updated ratings and commentary, is sharpening market attention on how these upcoming results could shape perceptions of Amrize’s outlook. We’ll now examine how the upcoming fourth-quarter earnings release and related analyst commentary may influence Amrize’s...
NYSE:RMD
NYSE:RMDMedical Equipment

ResMed (RMD) Net Margin Strength In Q2 2026 Supports Bullish Earnings Narrative

ResMed Q2 2026 earnings in focus ResMed (RMD) has just posted its Q2 2026 earnings, with revenue of about US$1.4b and basic EPS of US$2.69 setting the tone for the latest quarter. The company reported revenue of US$1,282.1m in Q2 2025 and US$1,422.8m in Q2 2026, while basic EPS over the same quarters moved from US$2.35 to US$2.69. This gives investors a clearer view of both top line and per share performance. With trailing net profit margins at 27.5% and earnings growth already in focus, this...
NYSE:LAZ
NYSE:LAZCapital Markets

Lazard Taps Insider Tracy Farr As CFO To Shape 2030 Plan

Lazard (NYSE:LAZ) has appointed Tracy Farr as its new Chief Financial Officer. The leadership change is intended to support the firm's long term growth and operational efficiency plans. Farr brings extensive internal experience at Lazard to the CFO role. Lazard, traded on the NYSE under the ticker NYSE:LAZ, recently closed at $53.72. The stock has seen a 4.6% return over the past week and 10.6% over the past month, with a 62.1% return over five years. In that context, a CFO transition can...